Literature DB >> 2004595

On the mechanisms for the selective action of vitamin D analogs.

A S Dusso1, L Negrea, S Gunawardhana, S Lopez-Hilker, J Finch, T Mori, Y Nishii, E Slatopolsky, A J Brown.   

Abstract

A variety of analogs of 1,25-(OH)2D3 with less calcemic activity and lower receptor binding affinity than 1,25-(OH)2D3 have been developed. However, these compounds have equal or greater ability to differentiate leukemia cells and psoriatic fibroblasts and to suppress PTH synthesis and secretion. The mechanism for this selectivity has not been elucidated. Because the lower potency of ergocalciferol compared to cholecalciferol in preventing or curing rickets in chicks was associated with a lower affinity of the avian vitamin D binding protein (DBP) for vitamin D2, we tested five analogs with low calcemic activity including 22-oxa-1,25-(OH)2D3 (OCT), MC903, 1,25-(OH)2-16 ene-23-yne D3, 1,25-(OH)2-26,27 dihomo-22-ene-D3, and 1,25-(OH)2-24-trihomo-22-ene-D3 for their affinity for rat serum DBP. All analogs had a low affinity for DBP, ranging from 50-3000 times less than that of 1,25-(OH)2D3. OCT also bound with low affinity to dog and human serum DBP. We tested with OCT the possible consequences of its low affinity for serum DBP. One of the functions of DBP is to prolong the lifetime of 1,25-(OH)2D3 in circulation. Quantification of the metabolic clearance rate (MCR) of OCT in 8 normal dogs using a single bolus injection technique showed that OCT was cleared at a rate of 48.2 +/- 7.5 ml/min, approximately 6-7 times more rapidly than 1,25-(OH)2D3 (6.8 +/- 0.4 ml/min). The estimated half-life of OCT in the circulation was 2.5 +/- 0.3 h compared to 7.0 +/- 0.6; n = 7 for 1,25-(OH)2D3. As our primary interest is the potential of OCT in treating the secondary hyperparathyroidism of CRF, we also measured the MCR of OCT in 5/6 nephrectomized dogs. Uremia does not affect the rate of clearance of OCT from the circulation (MCR: 56.8 +/- 4.5; t1/2 = 2.1 +/- 0.2 n = 4). Despite its shorter half-life, OCT suppressed PTH secretion in vivo in uremic dogs. The effects of low binding to DBP on the percentage uremic dogs. The effects of low binding to DBP on the percentage of free sterol were determined using an ultrafiltration procedure. We compared the proportion of free (unbound) OCT and 1,25-(OH)2D3 in 0.1% BSA-PBS with concentrations of human serum ranging from 0-25%. The proportion of OCT in the free form was significantly higher than that of 1,25-(OH)2D3 for every serum concentration tested. The physiological relevance of a higher percentage of free OCT was tested in normal human macrophages.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004595     DOI: 10.1210/endo-128-4-1687

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

Review 1.  The role of vitamin D in the endocrinology controlling calcium homeostasis.

Authors:  James C Fleet
Journal:  Mol Cell Endocrinol       Date:  2017-04-09       Impact factor: 4.102

2.  Hypovitaminosis D as predisposing factor for atrophic type A gastritis: a case-control study and review of the literature on the interaction of Vitamin D with the immune system.

Authors:  Antonio Antico; Renato Tozzoli; Davide Giavarina; Elio Tonutti; Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 3.  Vitamin D and its analogs in chronic renal failure.

Authors:  E Slatopolsky; A J Brown
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

4.  Vitamin D receptor gene polymorphism in children with urinary tract infection.

Authors:  Sule Aslan; Ipek Akil; Gulcin Aslan; Huseyin Onay; Beyhan Cengiz Ozyurt; Ferda Ozkinay
Journal:  Pediatr Nephrol       Date:  2011-09-25       Impact factor: 3.714

Review 5.  Rationale to reduce calcium intake in adult patients with chronic kidney disease.

Authors:  Sharon M Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-07       Impact factor: 2.894

6.  Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.

Authors:  G C van den Bemd; H A Pols; J C Birkenhäger; J P van Leeuwen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Effects of analogs of 1,25(OH)2 vitamin D3 on the proliferation and differentiation of the human chronic myelogenous leukemia cell line, RWLeu-4.

Authors:  J W Clark; M R Posner; J M Marsella; A Santos; M Uskokovic; C Eil; S R Lasky
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

8.  Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.

Authors:  D D Branisteanu; P Leenaerts; B van Damme; R Bouillon
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

9.  Growth inhibition of human colon adenocarcinoma-derived Caco-2 cells by 1,25-dihydroxyvitamin D3 and two synthetic analogs: relation to in vitro hypercalcemic potential.

Authors:  H S Cross; K H Farsoudi; M Peterlik
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000

Review 10.  Ascorbate on cell growth and differentiation.

Authors:  F J Alcaín; M I Burón
Journal:  J Bioenerg Biomembr       Date:  1994-08       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.